OraSure Technologies
OraSure Technologies, Targeted Genomics Collaborate for DTC Genetic Celiac Disease Testing
The collaboration is expected to expand consumer access to at-home celiac genetic testing.
OraSure's Q1 Core Revenues Down 2 Percent
The firm brought in revenues of $29.9 million in Q1, down 45 percent from $54.1 million in Q1 2024 but narrowly beating the consensus Wall Street estimate of $29.6 million.
OraSure Technologies Board Authorizes $40M Share Repurchase
The diagnostic test and sample management solutions developer intends to use cash on hand to fund the repurchase.
OraSure Technologies Q4 Core Revenues up 10 Percent, Beat Estimates
The firm reported a $40 million decline in COVID-19-related revenues for the recently completed quarter compared to a year ago.
JP Morgan Healthcare Conference, Day 4: Standard BioTools, Sera Prognostics, OraSure, Geneoscopy
Highlights from the fourth day included preliminary data from Sera Prognostics for its PreTRM blood test.
Jan 2, 2025
360Dx Top 30 Rebounds in 2024, Rises 4 Percent
Jul 11, 2024